Drug Approval | August 05, 2023
USFDA approves Merck’s ERVEBO for use in children 12 months of age and older
Merck continues progress in helping to protect people at risk of Zaire ebolavirus disease
Merck continues progress in helping to protect people at risk of Zaire ebolavirus disease
Qualicaps is the third largest producer of hard capsules for oral dosage solutions
Shilpa Medicare Limited is the first company to receive approval for Manufacturing & Market of Pemetrexed Injection 10 ml, 50 ml, 85 ml, and 100 ml in India
Contracts are related to a $487 million biotech expansion project in Denmark and first phase of a new life sciences production facility valued at $574 million in Central U.S.
Proposed acquisition represents meaningful step forward in Biogen’s strategy for sustainable growth
Acquisition of biologics manufacturing facility in Bangalore to complete by the end of the third quarter in FY 24
The net profit in the June quarter was also lower than Rs 146.3 crore reported in the March quarter.
If approved, KEYTRUDA would be the first immunotherapy for the first-line treatment of HER2-positive advanced gastric or GEJ cancer in tumors expressing PD-L1 (CPS ?1) in the EU
SMPA's diverse portfolio includes six marketed products and a robust pipeline of early- to late-stage assets
However, PAT growth will be lower than operating profit growth mainly due to brand amortization expenditure on account of acquisition.
Subscribe To Our Newsletter & Stay Updated
